A carregar...

Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease

OBJECTIVE: While systemic sclerosis-related interstitial lung disease (SSc-ILD) trials predominantly use forced vital capacity (FVC) as the primary outcome, combining individual outcomes may lead to a more comprehensive measure of treatment response and minimize the risk of type 1 error. The present...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Sunnyvale)
Main Authors: Volkmann, Elizabeth R, Tashkin, Donald P, Li, Ning, Furst, Daniel E, Clements, Philip J, Elashoff, Robert M
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5573239/
https://ncbi.nlm.nih.gov/pubmed/28856069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2161-1149.1000154
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!